Myasthenia gravis as a receptor disorder.
D000109:Acetylcholine / Q000378:metabolism*; D000200:Action Potentials; D000818:Animals; D001665:Binding Sites; D002038:Bungarotoxins / Q000378:metabolism; D003472:Curare / Q000494:pharmacology; D004195:Disease Models, Animal; D004558:Electric Stimulation; D005071:Evoked Potentials; D006801:Humans; D009045:Motor Endplate / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects; D009157:Myasthenia Gravis / Q000378:metabolism / Q000503:physiopathology*; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000503:physiopathology; D011955:Receptors, Drug
D002038:Bungarotoxins; D011955:Receptors, Drug; D009388:Neostigmine; D003472:Curare; D000109:Acetylcholine